Life science advisory · Launch, turnaround, cross-border market entry

Commercial Excellence with Purpose

We link execution to purpose: the benefit to society and to the end user.

Praxen Advisory Group embeds operator-grade commercial, financial, and fundraising leadership inside pharmaceutical, digital health, and medical device companies. We launch products in the U.S. market, turn around stalled growth, build the American presence for international innovators, and connect U.S. companies with partners across Asia-Pacific.

Approach

How we work

Operators, not observers

Every engagement is led by a principal who has carried a number: built the field team, run the launch, closed the round.

Outcomes on the invoice

Engagements are defined by prescribers captured, rounds closed, revenue growth, and retention held. Those are the metrics you report to your board.

Services

What we take on

In each area, we bring in key industry experts who are in the trenches today, building companies with the same skills they put to work for you.

U.S. market entry

For international life science companies establishing an American presence: market strategy, operating setup, first commercial hires, and the channel relationships to land the first accounts.

Asia-Pacific expansion

For U.S. life science companies going international: the connections and partner relationships to enter markets across Asia-Pacific.

Launch strategy and go-to-market design

Positioning, targeting, and channel design for selling into physician groups, hospitals, health systems, and government buyers.

Capital formation and investor readiness

Raise narrative, materials, and U.S. investor outreach that connect capital strategy to commercial execution.

Embedded operational and financial leadership

Fractional C-suite leadership inside your operating rhythm: board-grade reporting, launch discipline, and turnaround work when growth has stalled.

Field execution and sales enablement

Team design, hiring, incentive design, training, and cadence, built by people who have taken small teams past large ones. Market access work spans GPO, IDN, PBM, and payer contracting.

Government and institutional channels

Procurement pathways into health systems, EMS, the VA, and the Department of Defense, where credibility and process discipline win.

Regulatory support and uptake acceleration

FDA pathway and reimbursement planning alongside counsel, then adoption work inside health systems, EMS, and surgery centers for newly approved devices and drugs: value analysis committees, formulary, and P&T.

Expertise

Where we have depth

The sectors we know, the government buyers and policy work around them, the situations we are brought in for, and the people work that makes results last. In each one, we draw on experts who are doing the work now, across the industry.

Sectors

  • PharmaceuticalsSpecialty and branded products, from pre-launch through commercial scale.
  • Digital healthHealthcare SaaS and AI platforms sold to practices and health systems.
  • Medical devicesDevices sold into hospitals, acute care, and EMS.
  • Laboratory sciencesMarketing and management expertise for clinical laboratories and the hospitals and health systems they serve.

Government

  • Department of DefenseMilitary health buyers and the defense procurement process.
  • Veterans AffairsThe VA health system and its contracting pathways.
  • Policy and government relationsState and federal policy work that opens coverage and access.

Situations

  • Product launchesNew products and relaunches, planned and run from the field up.
  • TurnaroundsStalled growth diagnosed, rebuilt, and put back on forecast.
  • Asia-PacificMarket entry in both directions: the region's companies into the U.S., and U.S. companies into the region.

People

  • TrainingSales and leadership training built for the field, from onboarding to launch readiness.
  • DevelopmentCoaching that moves strong performers into leadership roles.
  • Culture buildingValues, incentives, and engagement practices that hold teams together through growth and change.

Buyers our clients sell to: physician groups, hospitals, health systems, surgery centers, EMS, the VA, and the Department of Defense.

About

An advisory bench built from operators

Praxen, from praxis: the practice of doing.

Praxen principals have led commercial organizations from four people to hundreds, taken products from pre-revenue to nine figures, and raised the capital to fund the climb.

Around them is a bench of industry experts still in the trenches, building companies today. We match their skill sets to each engagement.

For international teams, we are the partner on the ground. We have built U.S. commercial organizations from zero and know what American health systems and government buyers require before they sign.

For U.S. companies looking abroad, we work the same corridor in reverse, with connections across Asia-Pacific.

The person who sells your engagement is the person who leads it.

Principals

Paul Howe

Paul Howe

Founder and Managing Principal

Paul Howe is a healthcare operating executive with thirty years of commercial leadership at Sanofi Pharmaceuticals, Reliant, GlaxoSmithKline, XenoPort, AcelRx, and Protega Pharmaceuticals, where he most recently served as Chief Operating Officer. He has built national field organizations from the ground up, led launches and relaunches in specialty pharmaceuticals and acute care drug-device, and raised the capital to fund them.

Through Praxen he advises boards and CEOs on market entry, go-to-market design, and capital formation, and serves as Chief Development Officer of an AI-native healthcare SaaS company. He completed the General Management Program at Duke University's Fuqua School of Business, holds a B.A. in Business from Benedictine College, and is a Licensed Healthcare Administrator and certified executive coach.

Christy Sweet

Christy Sweet

Chief Advisor and Partner

Christy Sweet is a commercial leader with more than twenty-five years in pharmaceutical sales and field leadership at Reliant, Bristol-Myers Squibb, XenoPort, AcelRx, and Protega Pharmaceuticals, where she most recently served as Senior National Business Director. She has led national teams through product launches and turnarounds in acute pain, neurology, and cardiometabolic medicine, and as a national trainer designed the curricula that take a field organization from first hire to launch readiness.

A board-certified Medical Laboratory Scientist (ASCP), she pairs scientific fluency with commercial results: educating key opinion leaders, pharmacists, and prescribers on complex medicine, and winning adoption inside major academic medical centers and health systems. Before Praxen she founded Physician's Laboratory Services, a clinical consulting practice serving hospitals and integrated delivery networks, and CLS Consulting, providing senior leadership for recruiting, marketing, and management services. Through Praxen she leads field execution, training, and clinical education alongside client teams, turning in-services and protocol work into adoption that lasts. She holds a B.S. in Medical Technology from Kent State University.

Kevin Tseng

Kevin Tseng

Partner

Kevin Tseng is a biotechnology entrepreneur with nearly three decades of experience building companies in life sciences, clinical genomics, diagnostics, and drug delivery. He founded Prisma Biotech, AQUIVA GROUP Inc., Recentcare Biomedical, and ForDx, and co-founded MatchCure Inc.

At Praxen, he advises life science companies on Asia-Pacific opportunities, technology commercialization, and market entry. He holds a Master of Science in microbiology and immunology from National Taiwan University.

Praxen Senior Advisors

Brendan Cassidy

Senior Advisor

Brendan Cassidy is Co-Founder of DenRose Search Group, bringing more than twenty years of pharmaceutical and biotechnology industry expertise. He has built a strong reputation for partnering with emerging and mid-sized life sciences companies to identify and recruit exceptional talent and build high-performing commercial organizations.

Throughout his career, Brendan has supported pharmaceutical and biotechnology companies through critical stages of growth, including pre-FDA approval, product commercialization, and market expansion. His expertise spans sales, marketing, and market access, with a particular focus on building commercial teams from the ground up and aligning talent acquisition strategies with organizational objectives.

Through Praxen, Brendan advises clients on executive talent acquisition, organizational design, and commercial team development, helping life sciences companies establish the leadership and infrastructure necessary for successful product launches and sustainable growth. His extensive industry relationships, deep market knowledge, and proven ability to connect exceptional talent with strategic opportunities provide valuable insight to organizations navigating the evolving pharmaceutical and biotechnology landscape.

Jamie Mueller

Senior Advisor

James “Jamie” Mueller is an entrepreneur, innovator, former NFL athlete, and biotechnology executive whose career spans professional sports, healthcare leadership, and the development of human performance technology. He began his professional journey with a six-year career in the National Football League, playing fullback for the Buffalo Bills and starting in Super Bowl XXV. His path from a small college football program to the NFL reflects the determination, discipline, and competitive mindset that have defined his career since.

After football, Jamie built a 30-year career in the pharmaceutical and biotechnology industries, holding leadership positions with Sanofi, The Medicines Company, and Iveric Bio. Along the way he developed deep expertise in commercial strategy, business development, organizational leadership, and bringing new medical therapies to market.

Drawing on decades in elite athletics, biotechnology, and human physiology, Jamie founded MAXIMUS, a patented respiratory training technology built on a simple idea: breathing is a foundational and often overlooked component of human performance. The MAXIMUS system uses dual-resistance breathing technology to challenge respiratory function during exercise, with the goal of improving respiratory efficiency, cardiovascular conditioning, and physical performance. As founder, he is evolving MAXIMUS from a patented training device into a connected health and performance platform that integrates advanced sensors, real-time physiological feedback, personalized coaching, and subscription-based digital services, with the aim of establishing MAXIMUS as a leader at the intersection of respiratory science, wearable technology, preventive health, and human longevity.

From the NFL to biotechnology leadership to building his own patented technology company, Jamie’s career reflects a consistent commitment to innovation, perseverance, and challenging conventional limits. Learn more at trainmaximus.com.

Contact

Tell us what you're building

A short conversation is usually enough to know whether we're the right fit, and we'll tell you either way. Candor is a deliverable here.

Praxen Advisory Group General inquiries

Email info@praxenadvisorygroup.com

Christy Sweet Chief Advisor and Partner

Email csweet@praxenadvisorygroup.com